Abstract:Rationale. Pathological cardiac remodeling serves as a vital mechanism during the progression from myocardial infarction (MI) to chronic heart failure (CHF). Nobiletin (NOB), an active monomer extracted from the peel of citrus fruit, has been reported to have beneficial effects in cardiovascular diseases. Our study was aimed at describing the specific mechanisms through which NOB protects against pathological cardiac remodeling after MI. Materials and Methods. C57BL/6 mice were treated with coronary artery ligation to generate an MI model, followed by treatment for 3 weeks with NOB (50 mg/kg/d) or vehicle (50 mg/kg/d), with or without the peroxisome proliferator-activated receptor gamma (PPARγ) inhibitor T0070907 (1 mg/kg/d). Cardiac function (echocardiography, survival rate, Evans blue, and triphenyl tetrazolium chloride staining), fibrosis (Masson’s trichrome staining, quantitative real-time polymerase chain reaction (qRT-PCR), and western blot (WB)), hypertrophy (haematoxylin-eosin staining, wheat germ agglutinin staining, and qRT-PCR), and apoptosis (WB and terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) staining) were evaluated. Hypoxia-induced apoptosis (TUNEL, WB) and phenylephrine- (PE-) induced pathological hypertrophy (immunofluorescence staining, qRT-PCR) models were established in primary neonatal rat ventricular myocytes (NRVMs). The effects of NOB with or without T0070907 were examined for the expression of PPARγ and PPARγ coactivator 1α (PGC1α) by WB in mice and NRVMs. The potential downstream effectors of PPARγ were further analyzed by WB in mice. Results. Following MI in mice, NOB intervention enhanced cardiac function across three predominant dimensions of pathological cardiac remodeling, which reflected in decreasing cardiac fibrosis, apoptosis, and hypertrophy decompensation. NOB intervention also alleviated apoptosis and hypertrophy in NRVMs. NOB intervention upregulated PPARγ and PGC1α in vivo and in vitro. Furthermore, the PPARγ inhibitor abolished the protective effects of NOB against pathological cardiac remodeling during the progression from MI to CHF. The potential downstream effectors of PPARγ were nuclear factor erythroid 2-related factor 2 (Nrf-2) and heme oxygenase 1 (HO-1). Conclusions. Our findings suggested that NOB alleviates pathological cardiac remodeling after MI via PPARγ and PGC1α upregulation.

Protection of CAPE-pNO2 Against Chronic Myocardial Ischemia by the TGF-Β1/Galectin-3 Pathway In Vivo and In Vitro

Cardioprotection of CAPE-oNO2 Against Myocardial Ischemia/reperfusion Induced ROS Generation Via Regulating the SIRT1/eNOS/NF-κB Pathway in Vivo and in Vitro.

Protective Effects of P-Nitro Caffeic Acid Phenethyl Ester on Acute Myocardial Ischemia-Reperfusion Injury in Rats.

CAPE-pNO2 Attenuates Diabetic Cardiomyopathy Through the NOX4/NF-κB Pathway in STZ-induced Diabetic Mice.

Caffeic acid phenethyl ester possesses potent cardioprotective effects in a rabbit model of acute myocardial ischemia-reperfusion injury.

Caffeic Acid Phenethyl Ester Attenuates Pathological Cardiac Hypertrophy by Regulation of MEK/ERK Signaling Pathway in Vivo and Vitro

Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction Via Activating PPARγ and PGC1α

Inhibited Effects of CAPE-pNO2 on Cervical Carcinoma in Vivo and in Vitro and Its Detected Metabolites

Anti-colon Cancer Effect of Caffeic Acid P-Nitro-phenethyl Ester in Vitro and in Vivo and Detection of Its Metabolites.

Caffeic Acid Phenethyl Ester Inhibits the Progression of Elastase Induced Aortic Aneurysm in Rats

Caffeic acid mitigates myocardial fibrosis and improves heart function in post-myocardial infarction by inhibiting transforming growth factor-β receptor 1 signaling pathways

CAPE-pNO2 Ameliorated Diabetic Nephropathy Through Regulating the Akt/NF-κB/ Inos Pathway in STZ-induced Diabetic Mice

Caffeic Acid Phenethyl Ester Attenuates Liver Fibrosis Via Inhibition of TGF-β1/Smad3 Pathway and Induction of Autophagy Pathway

Protective Effects of Caffeic Acid Phenethyl Ester on Retinal Ischemia/reperfusion Injury in Rats.

CAPE-pNO2 Ameliorates Diabetic Brain Injury Through Modulating Alzheimer's Disease Key Proteins, Oxidation, Inflammation and Autophagy Via a Nrf2-dependent Pathway.

Effect of CAPE-pNO2 Against Type 2 Diabetes Mellitus Via the AMPK/GLUT4/ GSK3β/PPARα Pathway in HFD/STZ-induced Diabetic Mice.

Caffeic Acid Mitigates Myocardial Fibrosis and Improves Heart Function in Post-Myocardial Infarction by Inhibiting Transforming Growth Factor-8 Receptor 1 Signaling Pathways

Caffeic Acid Phenethyl Ester Protects Kidney Mitochondria against Ischemia/Reperfusion Induced Injury in an In Vivo Rat Model

Caffeic Acid Phenethyl Ester Inhibits Liver Fibrosis in Rats

Cinnamaldehyde protects cardiomyocytes from oxygen‐glucose deprivation/reoxygenation‐induced lipid peroxidation and DNA damage via activating the Nrf2 pathway

Mechanisms of cinnamic aldehyde against myocardial ischemia/hypoxia injury in vivo and in vitro: Involvement of regulating PI3K/AKT signaling pathway